Stem cell safety study for mild to moderate frailty
This study tests whether a single dose of a special stem cell treatment (HeXell-2020) is safe for older adults with mild to moderate frailty. Researchers want to see if it can help improve strength and daily function without causing serious side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 60 and 85 years old.
- You have mild to moderate frailty (need a little help with daily tasks but can still manage on your own).
- You are not taking strong immune-suppressing medicines like high-dose steroids.
- You do not have a serious brain or nerve disease like Parkinson's, dementia, or multiple sclerosis.
- You have not had a stem cell treatment in the past year or taken part in another experimental drug trial in the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program that combines exercise, social connection, and mental well-being activities to help older adults stay healthy and strong. It may improve your overall fitness and quality of life.
This trial tests a single intravenous dose of a stem cell product called Stemis™ in people aged 60 to 85 with mild to moderate frailty. The goal is to see if it is safe and tolerable, and whether it might help improve energy and function.
This study tests whether an experimental stem cell treatment called MiraMSC can help older adults with mild to moderate frailty. It aims to see if the treatment is safe and possibly improves energy or daily function.
This study tests an experimental stem cell product called StromaForte for people with aging frailty. It involves a single infusion of cells from a donor to see if it can improve strength and walking ability.
This early study (Phase 1) tests whether a lab-made stem cell product given through an IV is safe in people with “aging frailty.” It looks mainly at side effects and safety while also exploring whether the treatment can be given safely.
This trial tests a new stem cell treatment (HeXell-2020) for people with stable coronary artery disease. It aims to see if it's safe and can improve heart function. You may be eligible if you have stable angina and are on regular heart medications.
Hear when a new Frailty in Older Adults trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.